Mihaela Angelova
Mihaela Angelova
National Institute of Health and Medical Research of France
Verified email at crc.jussieu.fr
Title
Cited by
Cited by
Year
International validation of the consensus Immunoscore for the classification of colon cancer: a prognostic and accuracy study
F Pagès, B Mlecnik, F Marliot, G Bindea, FS Ou, C Bifulco, A Lugli, ...
The Lancet 391 (10135), 2128-2139, 2018
7572018
Pan-cancer immunogenomic analyses reveal genotype-immunophenotype relationships and predictors of response to checkpoint blockade
P Charoentong, F Finotello, M Angelova, C Mayer, M Efremova, D Rieder, ...
Cell reports 18 (1), 248-262, 2017
6862017
Integrative analyses of colorectal cancer show immunoscore is a stronger predictor of patient survival than microsatellite instability
B Mlecnik, G Bindea, HK Angell, P Maby, M Angelova, D Tougeron, ...
Immunity 44 (3), 698-711, 2016
5862016
Characterization of the immunophenotypes and antigenomes of colorectal cancers reveals distinct tumor escape mechanisms and novel targets for immunotherapy
M Angelova, P Charoentong, H Hackl, ML Fischer, R Snajder, ...
Genome biology 16 (1), 1-17, 2015
3162015
The tumor microenvironment and Immunoscore are critical determinants of dissemination to distant metastasis
B Mlecnik, G Bindea, A Kirilovsky, HK Angell, AC Obenauf, M Tosolini, ...
Science translational medicine 8 (327), 327ra26-327ra26, 2016
3092016
Evolution of metastases in space and time under immune selection
M Angelova, B Mlecnik, A Vasaturo, G Bindea, T Fredriksen, L Lafontaine, ...
Cell 175 (3), 751-765. e16, 2018
1662018
The link between the multiverse of immune microenvironments in metastases and the survival of colorectal cancer patients
M Van den Eynde, B Mlecnik, G Bindea, T Fredriksen, SE Church, ...
Cancer Cell 34 (6), 1012-1026. e3, 2018
972018
Immune evasion before tumour invasion in early lung squamous carcinogenesis
C Mascaux, M Angelova, A Vasaturo, J Beane, K Hijazi, G Anthoine, ...
Nature 571 (7766), 570-575, 2019
782019
The coordinated action of the MVB pathway and autophagy ensures cell survival during starvation
M Müller, O Schmidt, M Angelova, K Faserl, S Weys, L Kremser, ...
Elife 4, e07736, 2015
772015
miR-22 and miR-29a are members of the androgen receptor cistrome modulating LAMC1 and Mcl-1 in prostate cancer
L Pasqualini, H Bu, M Puhr, N Narisu, J Rainer, B Schlick, G Schäfer, ...
Molecular endocrinology 29 (7), 1037-1054, 2015
562015
Bioinformatics for cancer immunology and immunotherapy
P Charoentong, M Angelova, M Efremova, R Gallasch, H Hackl, J Galon, ...
Cancer Immunology, Immunotherapy 61 (11), 1885-1903, 2012
462012
Endosome and Golgi‐associated degradation (EGAD) of membrane proteins regulates sphingolipid metabolism
O Schmidt, Y Weyer, V Baumann, MA Widerin, S Eising, M Angelova, ...
The EMBO journal 38 (15), e101433, 2019
272019
Computational methods for gene finding in prokaryotes
M Angelova, S Kalajdziski, L Kocarev
ICT Innovations, 11-20, 2010
202010
The colorectal cancer immune paradox revisited
M Angelova, P Charoentong, H Hackl, Z Trajanoski
Oncoimmunology 5 (2), e1078058, 2016
102016
31st annual meeting and associated programs of the Society for Immunotherapy of cancer (SITC 2016): late breaking abstracts
S Althammer, K Steele, M Rebelatto, TH Tan, T Wiestler, G Schmidt, ...
Journal for ImmunoTherapy of Cancer 4 (2), 223-242, 2016
82016
TOR complex 2 (TORC2) signaling and the ESCRT machinery cooperate in the protection of plasma membrane integrity in yeast
O Schmidt, Y Weyer, S Sprenger, MA Widerin, S Eising, V Baumann, ...
Journal of Biological Chemistry 295 (34), 12028-12044, 2020
22020
Characterization of the evolution of immune response in lung squamous carcinogenesis
C Mascaux, M Angelova, J Beane, K Hijazi, G Antoine, KW Gallo, ...
Cancer Research 76 (14 Supplement), 1419-1419, 2016
12016
Characterisation of tumour immune microenvironment remodelling following oncogene inhibition in preclinical studies using an optimised imaging mass cytometry workflow
M Fv, K Valand, M Cole, H Patel, M Angelova, S Rana, E Colliver, ...
2021
Characterisation of tumour immune microenvironment remodelling following oncogene inhibition in preclinical studies using an optimised imaging mass cytometry workflow
F Van Maldegem, K Valand, M Cole, H Patel, M Angelova, S Rana, ...
The Francis Crick Institute, 2021
2021
Somatic chromosomal number alterations affecting driver genes inform in-vitro and clinical drug response in high-grade serous ovarian cancer
FC Martins, DL Couturier, I de Santiago, C Sauer, M Vias, M Angelova, ...
bioRxiv, 2020
2020
The system can't perform the operation now. Try again later.
Articles 1–20